Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-052-0 | CAS number: 60046-50-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 09/10 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The test was carried out in compliance with Directive 96/54/EEC, Part B.6 "Acute Toxicity - Skin Sensitization", 1992, and OECD Guideline for Testing of Chemicals No. 406 "Skin Sensitization", 1992, with no deviations reported.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Swiss Federal Department of the Interior
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- test was done before new regualtion entered into force
Test material
- Reference substance name:
- (4R,6R)-4-hydroxy-2,2,6-trimethylcyclohexan-1-one
- EC Number:
- 700-052-0
- Cas Number:
- 60046-50-6
- Molecular formula:
- C9H16O2
- IUPAC Name:
- (4R,6R)-4-hydroxy-2,2,6-trimethylcyclohexan-1-one
- Details on test material:
- - Name of test material (as cited in study report): Actinol
- Physical state: crystalline white powder
- Analytical purity: 99.5 %
- Lot/batch No.: 410016
- Expiration date of the lot/batch: 31 July 2000
- Storage condition of test material: at room temperature, protected from sun light
- Other:
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Ibm: GOHI (SPF)
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd Biotechnology & Animal Breeding Devision, Füllinsdorf, Switzerland
- Age at study initiation: 4-6 weeks
- Weight at study initiation: 360-401 g (pretest group), 352-392 g (main test and Controls)
- Housing: Individually in Makrolon type-4 cages with standard softwood bedding ("Lignocell", Schill-AG, Muttenz, Switzerland)
- Diet (e.g. ad libitum): standard Nafag Ecosan 845 25W4, batch nos. 64/99 and 79199, guinea pig breeding / maintenance diet (Nafag, Nahr- und Futtermittel AG, Gossau, Switzerland), ad libitum
- Water (e.g. ad libitum):Community tap water from Ftillinsdorf, ad libitum
- Acclimation period: no acclimatisation for prestes, one week for main test and Controls
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 40-70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: To:
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: PEG 400 was used for the intradermal and epicutaneous pretests. It was also used for the intradermal and epicutaneous induction and the challenge in the main test. A 1:1 mixture (v/v) of Freund's Complete Adjuvant:physiological saline was used as vehicle
- Concentration / amount:
- Based on the results of a pretest, a test substance concentration of 5 % was selected for the intradermal induction in the main study.
Based on the results of a pretest, the test substance concentrations in the epicutaneous induction and challenge in the main study were 50 % and 10 %, respectively.
Challengeopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- other: PEG 400 was used for the intradermal and epicutaneous pretests. It was also used for the intradermal and epicutaneous induction and the challenge in the main test. A 1:1 mixture (v/v) of Freund's Complete Adjuvant:physiological saline was used as vehicle
- Concentration / amount:
- Based on the results of a pretest, a test substance concentration of 5 % was selected for the intradermal induction in the main study.
Based on the results of a pretest, the test substance concentrations in the epicutaneous induction and challenge in the main study were 50 % and 10 %, respectively.
- No. of animals per dose:
- Test group: 10 male guinea pigs
- Details on study design:
- RANGE FINDING TESTS:
Range finding tests were performed with one male testing animal for the intradermal injections at concentrations of 1, 3, and 5 % of Actinol in PEG 400. Epicutaneous induction was tested in two male testing animals. Four patches of filter paper (3 x 3 cm) were saturated with the test substance at 10, 15, 25 and 50 % in PEG 400 and applied to the clipped and shaved flanks of the animals. Patches were covered by a strip of aluminium foil and firmly secured with elastic plaster wrapped around the trunk and covered with impervious adhesive tape.
MAIN STUDY
A. INDUCTION EXPOSURE (intradermal injections)
- No. of exposures: three pairs of intradermal injections
- Exposure period:
- Test groups: injection of 1:1 (v/v) FCA:physiological saline, injection of test substance at 5 % in PEG 400, injection of test substance at 5 % in 1:1 (v/v) FCA:physiological saline
- Control group: injection of 1:1 (v/v) FCA:physiological saline, injection of PEG 400, injection of 1:1 (w/w) mixture of PEG 400 in 1:1 (v/v) FCA:physiological saline
- Site: dorsal skin from the scapular region
- Frequency of applications: once
- Duration:
- Concentrations: 5 %
MAIN STUDY
A. INDUCTION EXPOSURE (epicutaneous)
- No. of exposures: one
- Exposure period: starting on Test Day 8
- Test groups: a 2 x 4 cm patch of filter paper was saturated with the test substance (50 % in PEG 400) and placed over the injection sites of the test animals
- Control group: a 2 x 4 cm patch of filter paper was saturated with PEG 400 and placed over the injection sites of the test animals
- Site: dorsal skin from the scapular region
- Frequency of applications: once
- Duration: 48 hours of occlusion with aluminium foil
- Concentrations: 50 %
B. CHALLENGE EXPOSURE
- No. of exposures: two
- Day(s) of challenge: the test and Control groups were challenged two weeks after the epicutaneous induction (Test Day 22) and were treated in the same way
- Exposure period: Test Day 22
- Test groups: clipped and shaved left flank was covered with a patch (3 x 3 cm) of filter paper saturated with the test substance ath the highest non-irritating concentraiton of 10 % , clipped and shaved right flank was covered with a patch (3 x 3 cm) of filter paper saturated with PEG 400
- Control group: clipped and shaved left flank was covered with a patch (3 x 3 cm) of filter paper saturated with the test substance ath the highest non-irritating concentraiton of 10 % , clipped and shaved right flank was covered with a patch (3 x 3 cm) of filter paper saturated with PEG 400
- Site: left and right flanks
- Concentrations: 10 %
- Evaluation (hr after challenge): the reaction sites were assessed 24 and 48 hours after the removal of the bandage
OTHER: - Challenge controls:
- five male guinea pigs
- Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10 % in PEG 400 or PEG 400 only
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no signs of systemic toxicity
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 10 % in PEG 400 or PEG 400 only. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no signs of systemic toxicity.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10 % in PEG 400 or PEG 400 only
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no signs of systemic toxicity
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 10 % in PEG 400 or PEG 400 only. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no signs of systemic toxicity.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10 % in PEG 400 or PEG 400 only
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no signs of systemic toxicity
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 10 % in PEG 400 or PEG 400 only. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no signs of systemic toxicity.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10 % in PEG 400 or PEG 400 only
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no signs of systemic toxicity
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 10 % in PEG 400 or PEG 400 only. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no signs of systemic toxicity.
Any other information on results incl. tables
no other remarks
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Based on the above mentioned findings in an adjuvant sensitization test in guinea pigs and in accordance to Commission Directive 96/54/EEC, Actinol has not to be classified and labelled as a skin sensitizer.
- Executive summary:
In order to assess the cutaneous allergenic potential of Actinol, the Maximization-Test was performed in 15 (10 test and 5 control) male albino guinea pigs, in accordance with OECD Guideline No. 406 and the Directive 96/54/EEC, B.6.
The intradermal induction of sensitization in the test group was performed in the nuchal region with a 5 % dilution of the test article in PEG 400 and in an emulsion of Freunds Complete Adjuvant (FCA) / physiological saline. The epidermal induction of sensitization
was conducted for 48 hours under occlusion with the test article at 50 % in PEG 400 one week after the intradermal induction. The animals of the control group were intradermally induced with PEG 400 and FCVphysiological saline and epidermally induced with PEG 400 underocclusion.
Two weeks after epidermal induction the control and test animals were challenged by epidermal application of the test article at 10 % in PEG 400 and PEG 400 alone under occlusive dressing. Cutaneous reactions were evaluated at 24 and 48 hours after removal of the dressing.
None of the 5 animals in the Control group and none of the 10 animals in the test group showed a positive reaction to the exposure to the test substance at 10 % in PEG 400 or to PEG 400 alone after 24 or 48 hours.
No toxic symptoms were evident in the guinea pigs of the control or test group. No deaths occurred.
Based on the above mentioned findings in an adjuvant sensitization test in guinea pigs and in accordance to Commission Directive 96/54/EEC, Actinol has not to be classified and labelled as a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.